Dr. Dang, a world-renowned scientist, medical oncologist, National Academy of Medicine member, and professor in Wistar’s Molecular and Cellular Oncogenesis Program, was selected for the 2020 Highly Cited Researchers list compiled by Clarivate Anal…
Predoctoral trainees Sarah Welsh and Joseph Zundell are the recipients of the annual Monica H. M. Shander Memorial Fellowship Award for outstanding predoctoral research. This year, the Committee has voted unanimously to split the award between bot…
Pratik Bhojnagarwala is a third-year graduate student in the Cancer Biology Program jointly administered by Wistar and the University of the Sciences. Currently, he’s carrying out thesis work in the Wistar lab of Dr. David Weiner, focusing on desi…
From the many corners of Philadelphia and its surrounding neighborhoods, Wistar colleagues united to run, walk and raise funds supporting our pre- and postdoctoral trainees. We had an amazing turn out, we all got our blood pumping on this brisk fa…
PHILADELPHIA — (Oct. 29, 2020) — Scientists at The Wistar Institute have designed and tested the first-of-its-kind synthetic DNA vaccine against Powassan virus (POWV), targeting portions of the virus envelope protein. A rapidly reemerging tick-bor…
Approaching the end of the year, Wistar takes stock of its federal funding performance. During the 2020 fiscal year of the National Institutes of Health (NIH) — the U.S. government agency that supports biomedical research, it funded Wistar researc…
PHILADELPHIA — (Oct. 13, 2020) — Researchers at The Wistar Institute and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the de…
PHILADELPHIA — (Oct. 13, 2020) — The Wistar Institute is pleased to welcome Scott Cooper, Ph.D., Richard G. Phillips Jr., Esq., and Steven V. Abramson, to its Board of Trustees. The new trustees bring diverse expertise and perspectives to the miss…
A conversation with Anne Schoemaker about her vision to sponsor The Wistar-Schoemaker International Postdoctoral Fellowship, a partnership launched in 2019 by Wistar and Leiden University Medical Center (LUMC) in the Netherlands to bring LUMC grad…
PHILADELPHIA — (Sept. 30, 2020) — Researchers at The Wistar Institute unraveled a mechanism employed by chronic lymphocytic leukemia (CLL) cells for their survival. According to the study, published online in Cellular & Molecular Immunology, m…
